← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Guilford Pharmaceuticals, Inc.
Baltimore, MD
$929,353
Total funding
6
Grants
Funding mix
By agency
NIH$929,353 · 6
By mechanism
R43$929,353 · 6
Investigators at Guilford Pharmaceuticals, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Immunophilin Ligands and Age-related Cognition$227,500
R43 · FY2005 · MH
Immunophilin Ligands and Age-related Cognition$227,500
R43 · FY2004 · MH
PSMA LIGANDS FOR TARGETED PROSTATE CANCER CHEMOTHERAPY$140,170
R43 · FY2003 · CA
PARP Inhibitors for Chemotherapy of Brain Tumors$107,000
R43 · FY2004 · CA
SERINE RACEMASE INHIBITION TO DECREASE NMDA-R ACTIVATION$97,500
R43 · FY2004 · NS
PARP Inhibitors for Treating Cardiac Arrest$95,013
R43 · FY2004 · HL
Therapeutic utility of glutaminase inhibitors$34,670
R43 · FY2005 · NS